Summary

Eligibility
for people ages 40 years and up (full criteria)
Location
at San Francisco, California
Dates
study started
estimated completion
Principal Investigator
by Chadwick Christine

Description

Summary

An extension study for participants who have completed a prior VY-AADC01 clinical study

Official Title

An Observational, Long-Term Extension Study for Participants in Prior VY-AADC01 Clinical Studies

Keywords

Parkinson's Disease Parkinson's Disease (PD) Gene Therapy Motor Fluctuations Neurosurgery NBIb-1817 Aromatic L-Amino Acid Decarboxylase Levodopa Dopamine AADC DDC AAV2-hAADC AAV VY-AADC Parkinson Disease

Eligibility

You can join if…

Open to people ages 40 years and up

  1. Completed participation in the PD-1101 or PD-1102 clinical study of VY-AADC01 gene therapy

You CAN'T join if...

None

Location

  • University of California, San Francisco
    San Francisco California 94143 United States

Lead Scientist at UCSF

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
Neurocrine Biosciences
ID
NCT03733496
Study Type
Observational
Last Updated